WTX101
Showing 1 - 17 of 17
Healthy Trial in Lincoln (ALXN1840 Enteric-coated Tablet, ALXN1840 Non-coated Capsule, Omeprazole)
Completed
- Healthy
- ALXN1840 Enteric-coated Tablet
- +2 more
-
Lincoln, NebraskaClinical Trial Site
Apr 1, 2022
Wilson Disease Trial in Austin (ALXN1840, Bupropion Hydrochloride)
Completed
- Wilson Disease
- ALXN1840
- Bupropion Hydrochloride
-
Austin, TexasClinical Trial Site
Jul 21, 2021
Wilson Disease Trial in Worldwide (ALXN1840, SoC Therapy)
Active, not recruiting
- Wilson Disease
- ALXN1840
- SoC Therapy
-
Los Angeles, California
- +53 more
May 2, 2022
Wilson Disease Trial in London (ALXN1840)
Completed
- Wilson Disease
-
London, United KingdomRichmond Pharmacology Ltd., St George's University of London
Nov 29, 2022
Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)
Recruiting
- Cancer
- +2 more
- engineered red blood cell WTX212
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People'S Hospital
Jan 21, 2023
Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)
Not yet recruiting
- Cholangiocarcinoma, Intrahepatic
- Recombinant Human Adenovirus Type 5
- HAIC of FOLFOX
-
Beijing, Beijing, ChinaBeijing Tsinghua Chang Gung Hospital
Mar 16, 2022
Copper Parameters in Wilson Disease Participants on Standard of
Completed
- Wilson Disease
- Standard of Care Medications
-
New Haven, Connecticut
- +9 more
Nov 16, 2020